Aiom: “Adjuvant therapy for breast cancer can change clinical practice”

Saverio Cinieri, president of Aiom at the Asco Congress, ‘Adjuvant therapy with ribociclib represents another great step forward for clinical research and the treatment of breast cancer. Italy played an important role in the international phase III trial Natalee’